Gavi, UNICEF announce new agreement to make R21/Matrix-M malaria vaccines more accessible
The deal, backed by Gavi and executed by United Nations Children’s Fund (UNICEF), is expected to generate up to $90 million in savings for Gavi and countries, equivalent to more than 30 million additional doses
Like
Comment
Share
